Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke tablets for acute exacerbation of chronic obstructive pulmonary disease
ChiCTR2300078547Phase 4Recruiting
- Sponsor
- Zhongshan Hospital, Fudan University
- Start
- Dec 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lianhua Qingke in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Zhongshan Hospital, Fudan University. Primary endpoint: Change from baseline in BCSS score. Started Dec 2023; status: recruiting.
02
Drugs
Lianhua Qingke
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2300078547.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078547.